A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
Key Details
- 1Researchers developed a deep learning model (SurvFinder) trained on whole slide histopathology images from stage II colorectal cancer patients.
- 2The study retrospectively analyzed multi-center data from patients in China and the United States.
- 3The AI model identified features associated with risk of recurrence at a higher success rate than traditional clinical prognostic tools.
- 4Study details and results are published in PLOS Medicine, open access.
Why It Matters
Digital pathology AI models can enhance prognostic accuracy and help personalize treatment plans for cancer patients. Outperforming current clinical tools could enable better risk stratification and improved outcomes in stage II colorectal cancer.
Source
EurekAlert
Related News
•EurekAlert
Researchers Develop All-Optical Synapse for Neuromorphic Imaging Systems
A new artificial synapse, controlled entirely by light, enables in-sensor neuromorphic processing for more efficient and noise-resistant imaging systems.
•EurekAlert
AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.
•EurekAlert
Ultrasound-Guided Nerve Freezing Revolutionizes Pediatric Ear Surgery Recovery
Lurie Children’s Hospital pioneers ultrasound-guided nerve freezing to eliminate prolonged postoperative pain in microtia repair.